Missed us at PEGS?
Couldn't make it to PEGS Boston Virtual Summit? Find out how Genedata efficiently supports the whole biopharmaceutical R&D workflow, including screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, stratification of clinical trial subjects, and quality control of biologicals.
Dealing with the Combinatorial Complexity of Protein Engineering
We present a new technology platform to fully automate both molecular design, as well as the integrated assessment of potency, efficacy, and developability profiling of large panels of bispecific candidates. We will present use cases showing how the platform allows for the systematic cloning, expression, purification, and characterization of complex multi-specific, CAR T and TCR modalities, with a focus on immuno-oncology applications.
Use Cases in Biopharma R&D
- Design and testing of complex bi- and multi-specific antibodies
- Immuno-oncology approaches: TCRs, TCR-mimetics, CAR T cell engineering
- Fc Receptor engineering - beyond ADCC and CDC
- Exploiting SPR for characterizing complex biologics
- Integrated developability and manufacturability assessment
- MS-based biotherapeutic characterization
- High-throughput cell line development
- NGS-based cell line characterization
- Scaled-down bioreactor-based process development
Built for Biopharma. Transforming Discovery Workflows.
Uniquely designed for biotherapeutic discovery, Genedata Biologics facilitates complex R&D processes by designing, tracking, testing, and assessing novel biotherapeutics in any format, including antibodies, bi- or multi-specifics, ADCs, novel scaffolds, therapeutic proteins, TCRs and CAR-T cells. Acting as a central end-to-end data backbone, Genedata Biologics integrates all R&D across biopharma workflows and automates lab instruments and robotics stations to enable true high-throughput processes. With a central, shared database, users at all levels of an organization have real-time access to all relevant data to enable data-driven decisions that empower R&D.
Purpose-built. Digitalizing Next-Generation Process Design.
Achieve operational excellence with the only platform uniquely built for the development of biotherapeutic drugs. Acting as a structured data backbone that integrates across biopharma workflows and automates lab instruments and robotics stations, Genedata Bioprocess ensures maximal efficiency along the whole end-to-end workflow. The platform supports cutting-edge technologies, such as highly parallel scale-down bioreactor panels, as well as complex DSP unit operations and sophisticated analytical techniques. Users at all levels of an organization get real-time access to all relevant data to enable data-driven decisions that empower R&D.
Industrialize. Improve Productivity.
By directly integrating with all laboratory instruments, such as bioreactors, downstream processing equipment, and analytics devices, Genedata Bioprocess automates data capture, which dramatically improves overall productivity and reduces manual errors. The platform can also be integrated with robotics equipment, enabling full automation and high-throughput processes, such as HT formulation screens.